Aidan Crawley is the founder of Amber Therapeutics. Amber Therapeutics has raised $100M in total funding. Latest round: Series A.
Aidan Crawley is the Co-Founder and CEO of Amber Therapeutics, a medical technology company that develops bioelectrical therapies for peripheral nervous system disorders. He led the company to secure a landmark $100 million Series A funding round in 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library